Rasmussen’s encephalitis (RE) is a neuroinflammatory disease that typically affects only one hemisphere of the brain, resulting in severe seizures. Sixty years after the disease was first described, the preferred and best treatment option for RE is grotesque and involves removing a hemisphere of the brain (hemispherectomy); therefore, a better understanding of this seizure disorder may provide additional, less invasive therapeutic options. In this issue of the JCI, Carmant and colleagues have developed an animal model of this focal seizure disorder. The model provides experimental insights into the pathogenesis of RE and potential new treatments for this disease.
Lawrence Steinman
Title and authors | Publication | Year |
---|---|---|
CNS autoimmune response in the MAM/pilocarpine rat model of epileptogenic cortical malformation.
Costanza M, Ciotti A, Consonni A, Cipelletti B, Cattalini A, Cagnoli C, Baggi F, de Curtis M, Colciaghi F |
Proceedings of the National Academy of Sciences | 2024 |
PET/CT imaging of CSF1R in a mouse model of tuberculosis.
Foss CA, Ordonez AA, Naik R, Das D, Hall A, Wu Y, Dannals RF, Jain SK, Pomper MG, Horti AG |
European Journal of Nuclear Medicine and Molecular Imaging | 2022 |
Fundamental mechanistic insights from rare but paradigmatic neuroimmunological diseases
H Wiendl, CC Gross, J Bauer, D Merkler, A Prat, R Liblau |
Nature Reviews Neurology | 2021 |